Subject of file

AbbVie Limited

file no.1297 active2014-03-03 – 2014-03-03 authorities1 spend areas0

Lane I

Solo awards

€0

awarded across 1 sole-awardee contract

The only credibly per-supplier-attributable money in this dossier — eTenders names a single awardee.

Lane II

Framework participations

multi-supplier frameworks · ceiling exposure €0

Per-supplier earnings cannot be derived — call-off splits between co-suppliers aren't in the source data. Read the count, not the money.

Lobbying register

50 matches

1 Sep, 2025 to 31 Dec, 2025 · Lobbyist: Abbvie Limited

A letter to the Minister for Health regarding the EU General Pharmaceutical Legislation (GPL)

1 May, 2025 to 31 Aug, 2025 · Lobbyist: Abbvie Limited

Urban Waste water treatment Directive

1 Jan, 2025 to 30 Apr, 2025 · Lobbyist: Abbvie Limited

Competitiveness of Europe and Ireland in relation to Life sciences

1 Sep, 2024 to 31 Dec, 2024 · Lobbyist: Abbvie Limited

Discussion with the Minister of state on quality of energy supply in Ireland

1 Sep, 2024 to 31 Dec, 2024 · Lobbyist: RPP SRL · Client: AbbVie|10 rue d'Arcueil, 94150 Rungis, [email protected]|[email protected]|+33 6

Commence dialogue with Irish MEPs to understand their perspectives on the EU’s competitiveness in relation to health policies and to explore potential alignment with the AbbVie's priorities.

1 May, 2024 to 31 Aug, 2024 · Lobbyist: Abbvie Limited

Meeting with officials from the Department of Health as part of a delegation from the US Chamber of Commerce, to discuss industry wide concerns in Ireland regarding the EU Commission’s proposals to revise the general pharmaceutical legislation.

1 Jan, 2024 to 30 Apr, 2024 · Lobbyist: Abbvie Limited

EU Pharmaceutical Strategy

1 Sep, 2023 to 31 Dec, 2023 · Lobbyist: Abbvie Limited

EU Pharmaceutical Strategy and Access to Medicines

1 Sep, 2023 to 31 Dec, 2023 · Lobbyist: Abbvie Limited

Access to Medicines

1 May, 2023 to 31 Aug, 2023 · Lobbyist: Abbvie Limited

EU Pharmaceutical Strategy and Access to Medicines

1 May, 2023 to 31 Aug, 2023 · Lobbyist: Abbvie Limited

EU Pharmaceutical Strategy

1 Jan, 2023 to 30 Apr, 2023 · Lobbyist: Abbvie Limited

Dermatology waiting lists

1 Sep, 2022 to 31 Dec, 2022 · Lobbyist: Abbvie Limited

1 May, 2022 to 31 Aug, 2022 · Lobbyist: Abbvie Limited

The need to speed up access to innovative medicines in Ireland, particularly in areas with high unmet need

1 Jan, 2022 to 30 Apr, 2022 · Lobbyist: Abbvie Limited

1 Sep, 2021 to 31 Dec, 2021 · Lobbyist: Abbvie Limited

Access to medicines in Ireland

1 Sep, 2021 to 31 Dec, 2021 · Lobbyist: Abbvie Limited

CSR activities - (corporate social responsibilities)

1 May, 2021 to 31 Aug, 2021 · Lobbyist: Abbvie Limited

Access and reimbursement to medicines

1 Jan, 2021 to 30 Apr, 2021 · Lobbyist: Abbvie Limited

Health Policy Engagement - Plant Closure

1 Sep, 2020 to 31 Dec, 2020 · Lobbyist: Q4PR · Client: Abbvie|14 Riverwalk, Citywest Business Campus, Citywest, Dublin, D24 XN32|[email protected]|3

Discussion about budget funds for innovative medicines

1 Sep, 2020 to 31 Dec, 2020 · Lobbyist: Abbvie Limited

Health Policy engagements

1 May, 2020 to 31 Aug, 2020 · Lobbyist: Abbvie Limited

World Hepatitis Day 2020

1 May, 2020 to 31 Aug, 2020 · Lobbyist: Abbvie Limited

Discussion about access to medicines

1 Jan, 2020 to 30 Apr, 2020 · Lobbyist: Abbvie Limited

Access to medicines and the European Intellectual Property (IP) protection environment

1 Sep, 2019 to 31 Dec, 2019 · Lobbyist: Abbvie Limited

Briefing note on access to medicines

25 additional matches not shown.

Top authorities

01 Tallaght University Hospital 1

Spend areas

Solo awards

1 record

Sole-awardee contracts. Awarded values reflect actual money paid to this supplier.

Date	Authority	Contract	Procedure	Estimated	Awarded
2014-03-03	Tallaght University Hospital	Supply, Delivery of Sevoflurane Products	Open Procedure	—	—

Framework participations

0 records

No multi-supplier framework participations on record.